Point prevalence survey of antibiotic use in Scottish hospitals utilising the Glasgow Antimicrobial Audit Tool (GAAT)

International Journal of Antimicrobial Agents

Volumn 29, Issue 6, 2007, Pages 693-699

  Seaton, R A ^a   Nathwani, D ^b   Burton, P ^c   McLaughlin, C ^d   MacKenzie, A R ^e   Dundas, S ^f   Ziglam, H ^b   Gourlay, Y ^a   Beard, K ^d   Douglas, E ^g  

^a GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^b NINEWELLS HOSPITAL   (United Kingdom)

^c STOBHILL HOSPITAL   (United Kingdom)

^d VICTORIA INFIRMARY   (United Kingdom)

^e ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^f MONKLANDS HOSPITAL   (United Kingdom)

^g NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

Author keywords

Antibiotic therapy; Antimicrobial therapy; Point prevalence study

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CETRIAXONE; CIPROFLOXACIN; FLUCLOXACILLIN; MEROPENEM; METRONIDAZOLE; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; TEICOPLANIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ABDOMINAL INFECTION; ALGORITHM; ARTICLE; DRUG USE; GLASGOW ANTIMICROBIAL AUDIT TOOL; HOSPITAL; HUMAN; MEDICAL AUDIT; PHYSICIAN; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SKIN INFECTION; SOFT TISSUE INFECTION; UNITED KINGDOM; URINARY TRACT INFECTION;

ADMINISTRATION, ORAL; ALGORITHMS; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; DATA COLLECTION; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; GLYCOPEPTIDES; HOSPITALS; HUMANS; INJECTIONS, INTRAVENOUS; METRONIDAZOLE; PREVALENCE; SCOTLAND;

EID: 34248212755     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2006.10.020     Document Type: Article

References (23)

1. Fraser G.L., Stogsdil P., Dickens J.D., et al. Antibiotic optimisation. An evaluation of patient safety and economic outcomes. Arch Intern Med 157 (1997) 1689-1694
2. Bodasing N., Cahill S., and Seaton R.A. Survey of antimicrobial prescribing in West Glasgow hospitals. J Infect 44 (2002) 113
3. Seaton R.A., Nathwani D., Phillips G., et al. Clinical record keeping in patients receiving antibiotics in general medical wards. Health Bull 57 (1999) 28-33
4. McLaughlin C.M., Bodasing N., Boyter A., Fenelon C., Fox J.G., and Seaton R.A. Pharmacy-implemented guidelines on switching from intravenous to oral antibiotics: an intervention study. Q J Med 98 (2005) 745-752
5. Gross R., Morgan A.S., Kinky D.E., et al. Impact of a hospital-based antimicrobial management program on clinical and economic outcomes. Clin Infect Dis 33 (2001) 289-295
6. Gomez J., Conde Cavero S.J., Hernanadez Cardona J.L., et al. The influence of the opinion of an infectious disease consultant on the appropriateness of antibiotic treatment in a general hospital. J Antimicrob Chemother 38 (1996) 309-314
7. Byl B., Clevenbergh P., Jacobs F., et al. Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteraemia. Clin Infect Dis 29 (1999) 60-66
8. Dancer S.J. The problem with cephalosporins. J Antimicrob Chemother 48 (2001) 463-478
9. Harbarth S., Garbino J., Pugin J., et al. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 115 (2003) 529-535
10. Seaton R.A., and Nathwani D. Rationale for sepsis management in immunocompetent adults. Edinburgh, UK: Proceedings of the Royal College of Physicians 30 (2000) 11-19
11. Scottish Infections Standards and Strategies (SISS group). Good practice guidance for antibiotic prescribing in hospital. J R Coll Phys Edinb 2003;33:281-4.
12. Scottish Executive Health Department Antimicrobial Prescribing Policy and Practice in Scotland. Recommendations for good antimicrobial prescribing in acute hospitals. Edinburgh, UK: Scottish Executive Health Department, 2005. http://www.show.scot.nhs.uk/sehd/cmo/CMO(2005)8report.pdf.
13. British Thoracic Society. Guidelines for the management of community acquired pneumonia in adults. Thorax 56 Suppl IV (2001) 1-55
14. Swedish Strategic Programme for the Antimicrobial Agents and Surveillance of Resistance (STRAMA); http://soapimg.icecube.snowfall.se/strama/Arsrapport_2003_ENG.pdf.
15. Bone R.C., Balk R.A., Cerra F.B., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101 (1992) 1644-1655
16. Skoog G, Cars O, Skarlund K, et al. Large scale nationwide point prevalence study of indications for antibiotic use in 54 Swedish hospitals in 2003. 14th ECCMID, Prague, 2004, poster 1186.
17. Dean B., Lawson W., Jacklin A., Rogers T., Azadian B., and Holmes A. The use of serial point-prevalence studies to investigate hospital anti-infective prescribing. Int J Pharm Pract 10 (2002) 121-125
18. Chan R., Hemeryck L., O'Regan M., Clancy L., and Feely J. Oral versus intravenous antibiotics for community acquired lower respiratory tract infection in a general hospital: randomised controlled trial. BMJ 310 (1995) 1360-1362
19. Al-Eidan F.A., McElnay J.C., Scott M.G., et al. Use of a treatment protocol in the management of community acquired lower respiratory tract infection. J Antimicrob Chemother 45 (2000) 387-394
20. Laing R.B.S., MacKenzie A.R., Shaw H., Gould I.M., and Douglas J.G. The effect of intravenous to oral switch guidelines on the use of parenteral antimicrobials in medical wards. J Antimicrob Chemother 42 (1998) 107-111
21. Sevinc F., Prins J.M., Koopmans R.P., et al. Early switch from intravenous to oral antibiotics: guidelines and implementation in a large teaching hospital. J Antimicrob Chemother 43 (1999) 601-606
22. Quarterly report on meticillin-resistant Staphylococcus aureus bacteraemia in Scotland, January 2001-June 2005. http://www.show.scot.nhs.uk/scieh/.
23. Ansari F., Gray K., Nathwani D., et al. Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis. J Antimicrob Chemother 52 (2003) 842-848